IDDF2024-ABS-0323 Fecal siderophore genes are potential biomarker for ulcerative colitis

<h3>Background</h3> Non-invasive biomarkers are currently recommended for assessing ulcerative colitis (UC) disease activity. Gut microbiome-related biomarkers are used as direct indicators of the intestinal microbiota and have considerable potential for disease assessment and therapeutic guidance in UC. This study aims to explore the relationship between fecal siderophore genes and UC activity and their potential value as a non-invasive biomarker to evaluate UC activity. <h3>Methods</h3> We included 166 patients with active UC (37 mild, 83 moderate, and 46 severe cases) and 165 healthy controls (HCs). Quantitative real-time PCR were used for the detection of eight siderophore genes, including enterobactin (entF, fepA), salmochelin (iroB, iroN), aerobactin (iucA, iutA), and yersiniabactin (irp1, fyuA). <h3>Results</h3> Patients with UC showed higher siderophore gene total copy number than HCs (1182.49 vs. 176.44 copies/ng, P&lt;0.01). A threshold of 2877.68 copies/ng distinguished patients with active UC from HCs, with 90.3% specificity and 33.1% sensitivity. Based on clinical disease activity, the total copy number of siderophore genes was significantly higher in patients with severe active UC than in those with moderate (3111.03 vs 1183.54 copies/ng, P&lt;0.05) and mild (3111.03 vs 672.60 copies/ng, P&lt;0.01) active UC. Moreover, patients with severe endoscopic activity exhibited an increased total copy number of fecal siderophore genes, higher than that in patients with mild-to-moderate endoscopic activity (1318.02 vs. 723.10 copies/ng, P&lt;0.05). A threshold of 10 298.63 copies/ng achieved 92.5% specificity and 43.5% sensitivity in identifying severe active UC, and 94% specificity and 22.5% sensitivity in identifying endoscopic severe active UC. In parallel test with serum C-reactive protein, the sensitivity and specificity increased to 89.1% and 75.8% for the clinical severe active stage and 55.2% and 88.0% for the endoscopic severe active stage, respectively. <h3>Conclusions</h3> Total siderophore gene copy number was positively correlated with both clinical and endoscopic disease activity in UC. The high prevalence and total copy number of bacterial siderophore genes indicated that they potentially serve as a novel non-invasive biomarker for UC activity.

Authors

Institutions

Publication Details

Published
2024-08-01
DOI
https://doi.org/10.1136/gutjnl-2024-iddf.128
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IDDF2024-ABS-0323 Fecal siderophore genes are potential biomarker for ulcerative colitis

Jingshuang Yan, Xiaoyan Chi, Lihua Peng, Xiaohan Zhang et al.
Gut microbiota and health
article

IDDF2024-ABS-0323 Fecal siderophore genes are potential biomarker for ulcerative colitis

Jingshuang Yan, Xiaoyan Chi, Lihua Peng, Xiaohan Zhang, Rongrong Ren, Zhengpeng Li, Wanyue Dan
article en

Abstract

<h3>Background</h3> Non-invasive biomarkers are currently recommended for assessing ulcerative colitis (UC) disease activity. Gut microbiome-related biomarkers are used as direct indicators of the intestinal microbiota and have considerable potential for disease assessment and therapeutic guidance in UC. This study aims to explore the relationship between fecal siderophore genes and UC activity and their potential value as a non-invasive biomarker to evaluate UC activity. <h3>Methods</h3> We included 166 patients with active UC (37 mild, 83 moderate, and 46 severe cases) and 165 healthy controls (HCs). Quantitative real-time PCR were used for the detection of eight siderophore genes, including enterobactin (entF, fepA), salmochelin (iroB, iroN), aerobactin (iucA, iutA), and yersiniabactin (irp1, fyuA). <h3>Results</h3> Patients with UC showed higher siderophore gene total copy number than HCs (1182.49 vs. 176.44 copies/ng, P&lt;0.01). A threshold of 2877.68 copies/ng distinguished patients with active UC from HCs, with 90.3% specificity and 33.1% sensitivity. Based on clinical disease activity, the total copy number of siderophore genes was significantly higher in patients with severe active UC than in those with moderate (3111.03 vs 1183.54 copies/ng, P&lt;0.05) and mild (3111.03 vs 672.60 copies/ng, P&lt;0.01) active UC. Moreover, patients with severe endoscopic activity exhibited an increased total copy number of fecal siderophore genes, higher than that in patients with mild-to-moderate endoscopic activity (1318.02 vs. 723.10 copies/ng, P&lt;0.05). A threshold of 10 298.63 copies/ng achieved 92.5% specificity and 43.5% sensitivity in identifying severe active UC, and 94% specificity and 22.5% sensitivity in identifying endoscopic severe active UC. In parallel test with serum C-reactive protein, the sensitivity and specificity increased to 89.1% and 75.8% for the clinical severe active stage and 55.2% and 88.0% for the endoscopic severe active stage, respectively. <h3>Conclusions</h3> Total siderophore gene copy number was positively correlated with both clinical and endoscopic disease activity in UC. The high prevalence and total copy number of bacterial siderophore genes indicated that they potentially serve as a novel non-invasive biomarker for UC activity.

Chinese PLA General Hospital (CN)
Zero hunger
Openalex Percentile: Top 88%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.